GERALDINE HENWOOD

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Jillian Dilmore, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GERALDINE HENWOOD:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Baudax Bio, Inc. President and CEO, Director Common Stock 2.43K $752 $0.31 15 Dec 2022 Direct
Baudax Bio, Inc. President and CEO, Director Common Stock 14 $4.00 $0.31 15 Dec 2022 By spouse
Baudax Bio, Inc. President and CEO, Director Stock Option (right to buy) 821K 22 Dec 2021 Direct
Recro Pharma, Inc. Director Stock Option (right to buy) 38K 20 Apr 2021 Direct

Insider Reports Filed by GERALDINE HENWOOD

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BXRX Baudax Bio, Inc. 15 Dec 2022 1 $3.06K 4 President and CEO, Director 19 Dec 2022, 07:09
BXRX Baudax Bio, Inc. 15 Jun 2022 1 $0 4 President and CEO, Director 17 Jun 2022, 16:10
BXRX Baudax Bio, Inc. 15 Dec 2021 2 -$5.78K 4 President and CEO, Director 23 Dec 2021, 16:45
BXRX Baudax Bio, Inc. 05 Dec 2021 1 -$3.2K 4 President and CEO, Director 14 Dec 2021, 17:27
BXRX Baudax Bio, Inc. 22 Sep 2021 1 $4.8K 4 President and CEO, Director 23 Sep 2021, 16:10
BXRX Baudax Bio, Inc. 07 May 2021 1 $4.99K 4 President and CEO, Director 10 May 2021, 16:12
SCTL Recro Pharma, Inc. 20 Apr 2021 1 $0 4/A Director 17 May 2021, 16:04